OpenAI launches AI model GPT-Rosalind for life sciences researchThe GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug ...
17 Apr, 2026, 12.44 AM IST
Demand for senior technology leaders in India is bucking a slowdown in broader tech hiringAs per experts, many MNCs are considering shifting global tech positions to India, mostly to their GCCs. Ratna Gupta, senior partner, ABC C...
13 Apr, 2026, 08.40 AM IST
UK to offer to pay more for some drugs to appease Trump: ReportThe British government will offer to pay more for medicines bought by the NHS, aiming to defuse U.S. President Donald Trump's complaints ab...
27 Sep, 2025, 08.25 AM IST
Global companies account for 60% of Indian vaccine sales by valueIndia's vaccine market is steadily recovering after the impact from Covid-19 and multinationals are back to slowly gaining traction, sugges...
21 Feb, 2024, 12.24 AM IST
Legacy pharma firm which sold 'Swadeshi' dysentery drug to Afghans waits and watches after Taliban takeoverThe company, which started out in a small garage on Hare Street, was set up as a 'Swadeshi enterprise' meant to take on the stranglehold of...
05 Sep, 2021, 05.50 PM IST
Kochi firm PNB Vesper Life Sciences completes phase 2 clinical trial of coronavirus drugThe company on Monday said the clinical trial was initiated in November at BJ Government Medical College and Sassoon General Hospital in Pu...
22 Feb, 2021, 05.01 PM IST
AstraZeneca shares sink 8% after $39 billion Alexion buyoutChief Executive Officer Pascal Soriot had told reporters on Saturday that the deal, a bet on rare-disease and immunology drugs, was the res...
14 Dec, 2020, 05.06 PM IST
British drug maker AstraZeneca may launch innovative drugs in IndiaBritish drug maker AstraZeneca is betting big on Asia including emerging markets such as India where it plans to introduce innovative produ...
14 Jan, 2016, 05.28 AM IST
AstraZeneca leaves door ajar to Pfizer, despite hurdlesAstraZeneca's boss said he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's ops int...
15 May, 2014, 06.09 AM IST
Wockhardt revenues may dip up to $250 m on USFDA banWockhardt may suffer an annual revenue fall of up to $250 million and its American operations may grind to a halt.
28 Nov, 2013, 09.27 AM IST
- American firm Abbott consolidates top position in Indian drug market
American firm Abbott Laboratories consolidated its top position in the Indian drug retail market by growing at a faster than its closest co...
19 Jul, 2011, 09.03 PM IST
- GlaxoSmithKline reports quarterly loss
British drugs firm GlaxoSmithKline on Thursday posted a net loss of £690 mn (813 mn euros, $1.119 bn) for the fourth quarter of 2010 on the...
03 Feb, 2011, 06.04 PM IST
- Glaxo in talks to buy India's Piramal Healthcare: Media report
British pharma major GlaxoSmithKline Plc is in discussions to acquire Indian generic drug maker Piramal Healthcare for nearly $1.5 billion,...
07 Feb, 2009, 02.12 PM IST
- Alkem recalls three lakh injections from abroad
Alkem alleges that Synergia and Centre Specialities Export Pharma were trying to malign the company after it decided to tap France & Africa...
10 Jul, 2008, 03.24 AM IST
- UK gets tough on pharma cos' clinical trials
Britain plans to force pharmaceutical companies to share more information with regulators about clinical trials after an investigation rece...
25 Mar, 2008, 12.45 AM IST
- Dr Reddy's enters into agreement with UK firm
Pharmaceutical major Dr Reddy's Laboratories today said it has entered into an agreement with British company SkyePharma Plc to undertake a...
08 Feb, 2008, 03.50 PM IST
- GSK to offer $15 bn for Pfizer unit: report
The British-based pharmaceutical group GlaxoSmithKline (GSK) is planning to offer more than $15 billion dollars for the consumer health car...
02 Jun, 2006, 09.25 AM IST